Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CTAS✓SelectedUSD · CTASMRNA vs CTAS performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs CTAS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.7%
CTAS return
+108.9%
Excess return
-130.6%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCTASExcessAlpha
1D-4.8%-0.1%-4.8%-4.8%
7D-20.9%-2.1%-18.8%-19.9%
30D-13.3%+4.8%-18.1%-15.9%
3M+212.6%+11.6%+201.0%+193.6%
6M+309.0%+27.8%+281.2%+253.9%
YTD+567.3%+19.2%+548.1%+495.1%
1Y+689.7%+21.9%+667.8%+595.9%
3Y+157.4%+66.3%+91.1%+66.1%
5Y-21.7%+110.2%-131.9%-64.9%
All-21.7%+108.9%-130.6%-64.9%

Cumulative growth

Daily Returns

Daily percentage return beside CTAS.

Daily Out/Under-Performance

Portfolio return minus CTAS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CTAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CTAS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling